Adam Savitz's most recent trade in Alto Neuroscience Inc. was a trade of 76,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 76,000 | 76,000 | - | - | Employee Stock Option (Right to Buy) | |
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 12.53 per share. | 09 Jul 2024 | 10,681 | 35,532 | - | 12.5 | 133,833 | Common Stock |
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 13.22 per share. | 09 Jul 2024 | 2,931 | 39,851 | - | 13.2 | 38,748 | Common Stock |
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 13.15 per share. | 09 Jul 2024 | 1,388 | 36,920 | - | 13.1 | 18,252 | Common Stock |
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 73,000 | 73,000 | - | - | Employee Stock Option (Right to Buy) | |
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 17,000 | 24,851 | - | 16 | 272,000 | Common Stock |
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | 06 Feb 2024 | 16,666 | 0 | - | - | Series B Preferred Stock | ||
Alto Neuroscience Inc. | Adam Savitz | CHIEF MEDICAL OFFICER | 06 Feb 2024 | 7,851 | 7,851 | - | - | Common Stock |